411
Participants
Start Date
September 30, 2011
Primary Completion Date
May 31, 2021
Study Completion Date
June 30, 2021
Rhythm control
Patients randomized to catheter ablation-based AF rhythm control group will receive optimal HF therapy and one or more aggressive catheter ablation, which include PV antral ablation and LA substrate ablation with or without adjunctive antiarrhythmic drug
Rate Control
Patients in the rate control group will receive optimal HF therapy and rate control measures to achieve a resting HR \< 80 bpm and 6-minute walk HR \< 110 bpm.
National Taiwan University Hospital, Taipei
Instituto de Cardiologia-FUC RS, Porto Alegre
Libin Cardiovascular Institute of Alberta, Calgary, Calgary
Royal Alexandra Hospital, Edmonton
Vancouver General, Vancouver
Royal Jubilee Hospital, Victoria
Queen Elizabeth II Health Science, Halifax
Hamilton Health Sciences Centre, Hamilton
Kingston General Hospital, Kingston
St. Mary's General Hospital, Kitchener
London Health Sciences Centre, London
Southlake Regional Health Care, Newmarket
University of Ottawa Heart Institute, Ottawa
Sunnybrook Health Sciences Centre, Toronto
Toronto General Hospital, University Health Network, Toronto
Institute de Cardiologie de Montréal, Montreal
CHUM Centre hospitalier universitaire de Montréal, Montreal
McGill University Health Centre, Montreal
Insitut universitaire de cardiologie and pneumologie de Quebec, Québec
CHUS Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke
Karolinska University Hospital, Stockholm
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Ottawa Heart Institute Research Corporation
OTHER